TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOLOGYONE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ONCOLOGYONE

ST13

US500000090196014

Class

9, 42

Filing

90196014

Registration

6783108

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

05/14/2025

Classification

Registered

Trademark type

Word

Nice classes

9, 42

Filing date

09/21/2020

Registration date

07/05/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/05/2022

Last transaction

05/14/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/26/2021

First use in commerce

10/26/2021

Drawing code

4

Owner type

99

Owner location

Ljubljana, SI

Examiner

BODRI, KRISTIN

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

C. D. (pessoa física)

Representatives

Paul Cosmovici

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Recorded computer software and hardware for use in radiotherapy machines and devices sold as a unit; Recorded computer software and hardware for use with patient positioning, monitoring, imaging and dosage delivery in the field of radiotherapy sold as a unit; Recorded computer software and hardware for managing system timing in radiotherapy applications sold as a unit; Recorded computer software and hardware for managing protection and safety in radiotherapy applications sold as a unit; Recorded medical software for digital enhancement and manipulation of radiological images, for use in the field of radiology and radiotherapy; Recorded medical software for dosimetry purposes in the field of radiotherapy; Recorded medical software for controlling and managing patient medical information in the field of radiology and radiotherapy; Recorded medical software for managing patient therapy workflow and treatment in radiotherapy

Class 42

Design and development of software and hardware for radiotherapy applications; Design and development of software and hardware for radiotherapy applications and radiology imaging; Design and development of software and hardware for medical particle accelerators; Design, development, and implementation of software for managing patient data for radiotherapy applications; Technological consultation in the technology field of radiotherapy engineering and radiology imaging; Technological planning and consulting services in the field of software and hardware for radiotherapy and radiology imaging

Publications

History of USPTO decisions and trademark events.

39 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/07/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/07/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/07/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/05/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/31/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/28/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/10/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/10/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/10/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/17/2022

GNRT

NON-FINAL ACTION E-MAILED

03/17/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

03/17/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/03/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/02/2022

IUAF

USE AMENDMENT FILED

02/08/2022

EISU

TEAS STATEMENT OF USE RECEIVED

02/08/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/24/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/24/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/24/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/23/2021

EX1G

SOU EXTENSION 1 GRANTED

09/21/2021

EXT1

SOU EXTENSION 1 FILED

09/21/2021

EEXT

SOU TEAS EXTENSION RECEIVED

09/21/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/11/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/16/2021

PUBO

PUBLISHED FOR OPPOSITION

03/16/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/24/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/11/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

02/11/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/11/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

02/11/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/11/2021

DOCK

ASSIGNED TO EXAMINER

02/05/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/24/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/24/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/24/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/29/2020

NWAP

NEW APPLICATION ENTERED

09/24/2020

Continuous trademark protection

Get notified about every new filing that threatens ONCOLOGYONE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.